A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs-Reference-Cited by-同舟云学术

A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

Published:2008-02 Issue:2 Volume:18 Page:99-107
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Lonjou Christine,Borot Nicolas,Sekula Peggy,Ledger Neil,Thomas Laure,Halevy Sima,Naldi Luigi,Bouwes-Bavinck Jan-Nico,Sidoroff Alexis,de Toma Claudia,Schumacher Martin,Roujeau Jean-Claude,Hovnanian Alain,Mockenhaupt Maja

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference25 articles.

1. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies;Lazarou;JAMA,1998

2. Cutaneous drug reactions;Svensson;Pharmacological Reviews,2001

3. Delayed drug hypersensitivity reactions;Pichler;Ann Int Med,2003

4. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis;Paul;Br J Dermatol,1996

5. Epidemiology of erythema exsudativum multiforme majus (EEMM), Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in Germany (1990–1992). Structure and results of a population based registry;Rzany;J Clin Epidemiology,1996

Cited by 548 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stevens–Johnson syndrome and toxic epidermal necrolysis: Updates in pathophysiology and management;Chinese Medical Journal;2024-09-05

2. Human leukocyte antigen class II (DRB1 and DQB1) alleles frequencies in patients with bullous pemphigoid, Stevens–Johnson syndrome and toxic epidermal necrolysis in Russian population;Russian Journal of Skin and Venereal Diseases;2024-08-04

3. Advances in Clinical Pharmacogenomics and Prevention of Severe Cutaneous Adverse Drug Reactions in the Era of Precision Medicine;Personalized Medicine - New Perspectives [Working Title];2024-07-17

4. Allopurinol: Clinical Considerations in the Development and Treatment of Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and Other Associated Drug Reactions;Cureus;2024-07-16

5. Hyperuricemia – consequences of not initiating therapy. Benefits and drawbacks of treatment;Rheumatology;2024-07-01